Kellner Capital’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Kellner Capital’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-120,100	Closed	-$5.77M	–	36
2020 Q1	$5.77M	Buy	120,100 +29,000	+32%	+$1.35M	2.67%	13
2019 Q4	$4.28M	Buy	+91,100	New	+$4.03M	2.71%	12

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Kellner Capital's RARX Position: Q2 2020 in Review

Kellner Capital sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 120,100 shares — an estimated $5.77M sold.

Kellner Capital first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $5.77M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Kellner Capital reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Kellner Capital sold 120,100 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $5.77M.
Kellner Capital first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Kellner Capital's Ra Pharmaceuticals, Inc. Common Stock position peaked at $5.77M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Kellner Capital's 13F filing for Q2 2020, filed 11 Aug 2020.